Latest News and Press Releases

TORONTO and HAIFA, Israel, June 04, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that on May 22, 2025,...

NurExone Biologic Inc. announces formation of a U.S.-based subsidiary, Exo-Top Inc. for fully characterized GMP Exosome production.

NurExone Biologic Secures Master Cell Bank - a Key Milestone for Therapeutic Exosome Production

Austin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The S&S Insider report indicates that, “The Mesenchymal Stem Cells (MSC) Market was valued at USD 3.2 Billion in 2023 and is projected to reach USD 9.72...

Selbyville, Delaware, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Spine Biologics Market size is expected to be worth USD 3.4 billion by 2032. The increasing prevalence of spine deformities is the major...

BRENTWOOD, Tenn., Sept. 09, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC” or “the Company”), today announces it has completed the third cohort of its Phase 1 clinical trial for...

New York, June 27, 2022 (GLOBE NEWSWIRE) -- The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the...

BRENTWOOD, Tenn., Feb. 16, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the second cohort of its Phase 1 clinical trial for...

LOS ANGELES, May 19, 2021 (GLOBE NEWSWIRE) -- The Global Mesenchymal Stem Cells Market is expected to grow at a CAGR of around 7.1% from 2020 to 2027 and reach the market value of over US$ 2,600.5...

Newark, NJ, Sept. 09, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global autologous cell therapy market is expected to grow from USD 9.29 billion in 2019 and to reach...